Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct-acting antiviral therapy effect on DNA telomere in hepatitis C virus-related cirrhosis
PACTR201804003186772Completed
- Sponsor
- Alexandria Faculty of Medicine
- Start
- Oct 2016
- Countries
- 1
01
Overview
Open-label trial in hepatitis C virus infection and Cirrhosis (2 arms), sponsored by Alexandria Faculty of Medicine. Primary endpoint: Cure of experimental group receiving therapy. Started Oct 2016; status: completed.
02
Conditions
hepatitis C virus infectionCirrhosis
Beyond the preview
Go deeper on PACTR201804003186772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201804003186772.